Medical Device Maker Broncus Gets Financial Breathing Room from IPO 堃博醫療從IPO中獲得財務上的喘息
Investors are betting company can quickly ramp up sales for its core pulmonary devices, most of which have been approved or are near approval in China, the U.S. and Europe 投資者押注該公司能夠迅速提高其核心肺部治療設備的銷售，其中大部分設備已經在中國、美國和歐洲獲得批準或即將獲得批準。
Bamboo Works (official website) provides news on Chinese companies listed in Hong Kong and the United States, with a strong focus on mid-cap and also pre-IPO companies.